EXPERTS have cautioned patients not to suddenly stop using a drug to control high blood pressure that was recalled from Bahrain’s market earlier this month.
China-manufactured Valsartan was taken off Bahrain’s shelves on July 8 after the European Medicines Agency (EMA) confirmed it contained harmful ingredients that could lead to cancer .